Literature DB >> 22777993

A 69-year-old man with a painful vesicular rash.

Derek R MacFadden1, Wayne L Gold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22777993      PMCID： PMC3447017          DOI： 10.1503/cmaj.120480

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

Review 1.  Clinical practice. Herpes zoster.

Authors:  John W Gnann; Richard J Whitley
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

Review 2.  Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials.

Authors:  Elissa M McDonald; Johannes de Kock; Felix S F Ram
Journal:  Antivir Ther       Date:  2011-12-15

3.  The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial.

Authors:  D Bowsher
Journal:  J Pain Symptom Manage       Date:  1997-06       Impact factor: 3.612

4.  Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.

Authors:  Kenneth E Schmader; Myron J Levin; John W Gnann; Shelly A McNeil; Timo Vesikari; Robert F Betts; Susan Keay; Jon E Stek; Nickoya D Bundick; Shu-Chih Su; Yanli Zhao; Xiaoming Li; Ivan S F Chan; Paula W Annunziato; Janie Parrino
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

5.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

Review 6.  Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia.

Authors:  John S Edelsberg; Claudia Lord; Gerry Oster
Journal:  Ann Pharmacother       Date:  2011-11-15       Impact factor: 3.154

7.  Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Authors:  R J Whitley; H Weiss; J W Gnann; S Tyring; G J Mertz; P G Pappas; C J Schleupner; F Hayden; J Wolf; S J Soong
Journal:  Ann Intern Med       Date:  1996-09-01       Impact factor: 25.391

Review 8.  Antiviral treatment for preventing postherpetic neuralgia.

Authors:  Qifu Li; Ning Chen; Jie Yang; Muke Zhou; Dong Zhou; Quanwei Zhang; Li He
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

9.  A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.

Authors:  Barbara P Yawn; Patricia Saddier; Peter C Wollan; Jennifer L St Sauver; Marge J Kurland; Lina S Sy
Journal:  Mayo Clin Proc       Date:  2007-11       Impact factor: 7.616

10.  A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.

Authors:  M J Wood; R W Johnson; M W McKendrick; J Taylor; B K Mandal; J Crooks
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.